William Aliski, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 29,400 shares at $68.65 ($2.1M) on 2015-05-12, disclosed to the SEC on 2018-10-09.
Open-market sale of $2.1M RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.65 | 10,500 | $721K | 34.3% |
| 2 | $68.65 | 10,500 | $721K | 34.3% |
| 3 | $85.94 | 2,000 | $172K | 8.2% |
| 4 | $122.58 | 400 | $49K | 2.3% |
| 5 | $73.38 | 6,000 | $440K | 20.9% |
| Total | $71.53 avg | 29,400 |
| $2.1M |
| 100% |
| Filing → |
| RARE | SELL | 2020-06-03 | $1.5M | — | Filing → |
| RARE | SELL | 2020-05-20 | $560K | — | Filing → |
| AGTC | BUY | 2018-12-18 | $19K | — | Filing → |